Author Archives: yun

Blood center, tissue center rebrand as Solvita

Deriving its new name from words meaning “sun” and “life,” the previously named Community Blood Center and Community Tissue Center is being rebranded as Solvita. “We have been impacting lives for decades, but under dual identities,” Solvita CEO Christopher Graham said during a Friday event. “We now have one name that uniquely represents our purpose, […]

What’s Going Around: COVID cases, other respiratory infections tick up, temperature swings cause breathing problems

Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local doctors and hospitals. Wayne County – COVID, asthma flare-ups, seasonal allergies, mononucleosis, ear infections, bug bites and stings Dr. Kevin Dazy — Pediatrician at Children’s Hospital of Michigan “I don’t want to alarm people, but we’re […]

CDC warns about deadly Vibrio infections

Kevin Rodriguez Ortiz / Flickr cc More than half of US dog owners surveyed mistrust routine vaccines for their pets, according to a new study in Vaccine. Researchers from Massachusetts, Pennsylvania, and Colorado conducted the survey of 2,200 US adults from March 30 to April 10, 2023, in partnership with sampling firm YouGov. They found […]

International consortium to study link between RSV infection and chronic respiratory tract diseases

UMC Utrecht will lead an international consortium that will try to answer a key question that’s in the mind of many pediatricians, infectiologists, pulmonologists and other health professionals: “Why are children that had an RSV infection in early childhood at increased risk of developing asthma later in life?” The project – which will run for […]

Momelotinib Could Represent Pivotal New Treatment Option in Myelofibrosis

Aaron T. Gerds, MD, MS The benefits in symptom burden, spleen size, and transfusion dependence demonstrated by treatment momelotinib in patients with myelofibrosis represent a potential key advance for this treatment paradigm, according to Aaron T. Gerds, MD, PhD. A new drug application (NDA) seeking the approval of momelotinib as a potential therapeutic option in […]

New study findings your family needs to know

E. coli infections that are immune to the antibiotic ciprofloxacin, a common treatment, are on the rise despite a six-year decrease in prescribing the treatment. That bucks what’s expected to happen. According to the study of Seattle-area women 50 and older who had not used any antibiotics for more than a year, cases of ciprofloxacin-resistant […]

LDL not the be all, end all in heart disease, heart attacks and stroke

image: Ze Zheng, MBBS, PhD — assistant professor of medicine (endocrinology and molecular medicine) at the Medical College of Wisconsin (MCW); co-leader of the MCW Cardiovascular Center’s Atherosclerosis, Thrombosis and Vascular Biology Program; and associate investigator at Versiti Blood Research Institute view more  Credit: Medical College of Wisconsin Milwaukee, Wis. – Sept. 1, 2023 – Despite […]

10 Best Blood Pressure Machines for 2023

Our Top Picks Monitoring your blood pressure is essential in maintaining good health, especially with heart disease being the leading cause of death globally. With so many options available, choosing the right blood pressure machine can be overwhelming. That’s why we’ve researched and tested various machines on the market, analyzing factors such as accuracy, ease […]

Rice EMS to hold blood drive Sept. 12

The American Red Cross estimates that every two seconds someone in the United States is in need of blood. Blood is essential to help patients survive surgeries, cancer treatment, chronic illnesses and traumatic injuries. Rice University Emergency Medical Services (REMS) will help the university community answer the call by hosting a blood drive on campus […]

Dr Islam on the Limited Use of Ibrutinib in CLL

Prioty Islam, MD, MSc, attending physician, medical oncologist, Leukemia, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, discusses the current status of the first-generation BTK inhibitor ibrutinib (Imbruvica) following the FDA approvals of next-generation BTK inhibitors in patients with chronic lymphocytic leukemia (CLL) and expands on the few instances in the clinic where she […]